Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia

医学 肝病学 肝移植 肝硬化 肝病 重症监护医学 内科学 移植
作者
Ashok Choudhury,Anand V. Kulkarni,Vinod Arora,A. S. Soin,A. Kadir Dökmeci,Abhijit Chowdhury,Abraham Koshy,Ajay Duseja,Ajay Kumar,Ajay Mishra,Ajay Kumar Patwa,Ajit Sood,Akash Roy,Akash Shukla,Albert C. Y. Chan,Aleksander Krag,Amar Mukund,Ameet Mandot,Amit Goel,Amna Subhan Butt
出处
期刊:Hepatology International [Springer Nature]
卷期号:19 (1): 1-69 被引量:2
标识
DOI:10.1007/s12072-024-10773-4
摘要

Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the working party of the Asian Pacific Association for the Study of the Liver (APASL) set in 2004 on ACLF was published in 2009, and the "APASL ACLF Research Consortium (AARC)" was formed in 2012. The AARC database has prospectively collected nearly 10,500 cases of ACLF from various countries in the Asia-Pacific region. This database has been instrumental in developing the AARC score and grade of ACLF, the concept of the 'Golden Therapeutic Window', the 'transplant window', and plasmapheresis as a treatment modality. Also, the data has been key to identifying pediatric ACLF. The European Association for the Study of Liver-Chronic Liver Failure (EASL CLIF) and the North American Association for the Study of the End Stage Liver Disease (NACSELD) from the West added the concepts of organ failure and infection as precipitants for the development of ACLF and CLIF-Sequential Organ Failure Assessment (SOFA) and NACSELD scores for prognostication. The Chinese Group on the Study of Severe Hepatitis B (COSSH) added COSSH-ACLF criteria to manage hepatitis b virus-ACLF with and without cirrhosis. The literature supports these definitions to be equally effective in their respective cohorts in identifying patients with high mortality. To overcome the differences and to develop a global consensus, APASL took the initiative and invited the global stakeholders, including opinion leaders from Asia, EASL and AASLD, and other researchers in the field of ACLF to identify the key issues and develop an evidence-based consensus document. The consensus document was presented in a hybrid format at the APASL annual meeting in Kyoto in March 2024. The 'Kyoto APASL Consensus' presented below carries the final recommendations along with the relevant background information and areas requiring future studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天天快乐应助深藏blue采纳,获得10
1秒前
2秒前
一弦完成签到 ,获得积分10
2秒前
大个应助橙子采纳,获得10
3秒前
fkljdaopk完成签到,获得积分10
3秒前
Cc完成签到 ,获得积分10
3秒前
科研通AI6.1应助lijingqi采纳,获得10
4秒前
Arlene发布了新的文献求助10
4秒前
4秒前
情怀应助奋斗向日葵采纳,获得10
4秒前
lingguangyi发布了新的文献求助10
6秒前
ycw发布了新的文献求助50
6秒前
11完成签到,获得积分20
7秒前
8秒前
万物生完成签到,获得积分10
8秒前
打打应助入暖采纳,获得10
9秒前
和平使命应助山水之乐采纳,获得20
9秒前
9秒前
10秒前
陈秋完成签到,获得积分10
11秒前
小马甲应助declan采纳,获得10
12秒前
13秒前
13秒前
13秒前
14秒前
14秒前
15秒前
16秒前
lingguangyi完成签到,获得积分20
17秒前
搜集达人应助kdfdds采纳,获得10
18秒前
19秒前
19秒前
20秒前
彭海炼发布了新的文献求助10
20秒前
入暖发布了新的文献求助10
20秒前
科研通AI6.2应助Arlene采纳,获得10
20秒前
李爱国应助老婶子采纳,获得10
20秒前
嘉佳伽完成签到,获得积分10
21秒前
21秒前
含蓄君浩发布了新的文献求助10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6019020
求助须知:如何正确求助?哪些是违规求助? 7610840
关于积分的说明 16160859
捐赠科研通 5166740
什么是DOI,文献DOI怎么找? 2765437
邀请新用户注册赠送积分活动 1747113
关于科研通互助平台的介绍 1635460